4 The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP-Reference-Cited by-同舟云学术

4 The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP

Published:1996-06 Issue:2 Volume:9 Page:259-271
ISSN:0950-3536
Container-title:Baillière's Clinical Haematology
language:en
Short-container-title:Baillière's Clinical Haematology

Author:

Berntorp Erik

Publisher

Elsevier BV

Subject

Hematology

Reference53 articles.

1. Frequency of inhibitor development in haemophiliacs treated with low purity factor VIII;Addiego;Lancet,1993

2. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B;Ahlberg;Acta Orthopaedica Scandinavica,1965

3. A longitudinal study of orthopaedic outcomes for severe factor VIII-deficient-hemophiliacs;Aledort;Journal of Internal Medicine,1994

4. Dose requirement for replacement therapy in hemophilia A;Allain;Thrombosis and Haemostasis,1979

5. Prophylaxis in haemophilia: a double-blind controlled trial;Aronstam;British Journal of Haematology,1976

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for Blood Product Management, Reducing Transfusions, and Massive Blood Transfusion;A Practice of Anesthesia for Infants and Children;2019

2. Treatment of musculo-skeletal pain in haemophilia;Blood Reviews;2018-03

3. Adult severe haemophilia A patients under long-term prophylaxis with factor VIII in routine clinical practice;Blood Coagulation & Fibrinolysis;2015-07

4. The role of physical medicine and rehabilitation in haemophiliac patients;Blood Coagulation & Fibrinolysis;2013-01

5. A sensitive venous bleeding model in haemophilia A mice: effects of two recombinant FVIII products (N8 and Advate®);Haemophilia;2012-04-16